Early development of infants with neurofibromatosis type 1: a case series

被引:18
|
作者
Kolesnik, Anna May [1 ,2 ]
Jones, Emily Jane Harrison [1 ,2 ]
Garg, Shruti [3 ,4 ]
Green, Jonathan [3 ,4 ]
Charman, Tony [5 ]
Johnson, Mark Henry [1 ,2 ]
机构
[1] Birkbeck Univ London, Ctr Brain & Cognit Dev, Malet St, London WC1E 7HX, England
[2] Birkbeck Univ London, Dept Psychol, Malet St, London WC1E 7HX, England
[3] Univ Manchester, Manchester Acad, Neurosci & Expt Psychol, Hlth Sci Ctr, Manchester, Lancs, England
[4] Cent Manchester Univ Hosp NHS Fdn, Royal Manchester Childrens Hosp, Manchester, Lancs, England
[5] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol, London, England
来源
MOLECULAR AUTISM | 2017年 / 8卷
关键词
NF1; Infant; Translational neurodevelopment; Autism; Prospective longitudinal; Adaptive functioning; Cognition; Sensory processing; Social engagement; Development; AUTISM SPECTRUM DISORDER; YOUNG-CHILDREN; HIGH-RISK; COGNITIVE DYSFUNCTION; 6-MONTH-OLD INFANTS; LEARNING-DEFICITS; MOUSE MODEL; PREVALENCE; ATTENTION; TEMPERAMENT;
D O I
10.1186/s13229-017-0178-0
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Prospective studies of infants at familial risk for autism spectrum disorder (ASD) have yielded insights into the earliest signs of the disorder but represent heterogeneous samples of unclear aetiology. Complementing this approach by studying cohorts of infants with monogenic syndromes associated with high rates of ASD offers the opportunity to elucidate the factors that lead to ASD. Methods: We present the first report from a prospective study of ten 10-month-old infants with neurofibromatosis type 1 (NF1), a monogenic disorder with high prevalence of ASD or ASD symptomatology. We compared data from infants with NF1 to a large cohort of infants at familial risk for ASD, separated by outcome at age 3 of ASD (n = 34), atypical development (n = 44), or typical development (n = 89), and low-risk controls (n = 75). Domains assessed at 10 months by parent report and examiner observation include cognitive and adaptive function, sensory processing, social engagement, and temperament. Results: Infants with NF1 showed striking impairments in motor functioning relative to low-risk infants; this pattern was seen in infants with later ASD from the familial cohort (HR-ASD). Both infants with NF1 and the HR-ASD group showed communication delays relative to low-risk infants. Conclusions: Ten-month-old infants with NF1 show a range of developmental difficulties that were particularly striking in motor and communication domains. As with HR-ASD infants, social skills at this age were not notably impaired. This is some of the first information on early neurodevelopment in NF1. Strong inferences are limited by the sample size, but the findings suggest implications for early comparative developmental science and highlight motor functioning as an important domain to inform the development of relevant animal models. The findings have clinical implications in indicating an important focus for early surveillance and remediation in this early diagnosed genetic disorder.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Early differences in auditory processing relate to Autism Spectrum Disorder traits in infants with Neurofibromatosis Type I
    Jannath Begum-Ali
    Anna Kolesnik-Taylor
    Isabel Quiroz
    Luke Mason
    Shruti Garg
    Jonathan Green
    Mark H. Johnson
    Emily J. H. Jones
    Journal of Neurodevelopmental Disorders, 2021, 13
  • [32] Recommendations for Social Skills End Points for Clinical Trials in Neurofibromatosis Type 1
    Janusz, Jennifer A.
    Klein-Tasman, Bonita P.
    Payne, Jonathan M.
    Wolters, Pamela L.
    Thompson, Heather L.
    Martin, Staci
    de Blank, Peter
    Ullrich, Nicole
    del Castillo, Allison
    Hussey, Maureen
    Hardy, Kristina K.
    Haebich, Kristina
    Rosser, Tena
    Toledo-Tamula, Mary Anne
    Walsh, Karin S.
    NEUROLOGY, 2021, 97 (07) : S73 - S80
  • [33] Neurofibromatosis Type 1 Implicates Ras Pathways in the Genetic Architecture of Neurodevelopmental Disorders
    Kaczorowski, Jessica A.
    Smith, Taylor F.
    Shrewsbury, Amanda M.
    Thomas, Leah R.
    Knopik, Valerie S.
    Acosta, Maria T.
    BEHAVIOR GENETICS, 2020, 50 (04) : 191 - 202
  • [34] Neurofibromatosis Type 1 Revisited
    Williams, Virginia C.
    Lucas, John
    Babcock, Michael A.
    Gutmann, David H.
    Korf, Bruce
    Maria, Bernard L.
    PEDIATRICS, 2009, 123 (01) : 124 - 133
  • [35] Case report: Benign and malignant tumors in adult patients with neurofibromatosis type 1: a comprehensive case series from a large oncologic reference center
    Vidal-Millan, Silvia
    Zatarain-Barron, Zyanya Lucia
    Daza-Galicia, Kena
    Shveid Gerson, Daniela
    Pichardo-Rojas, Pavel Salvador
    Salazar-Pigeon, Alejandro
    Wegman-Ostrosky, Talia
    FRONTIERS IN ONCOLOGY, 2024, 13
  • [36] Nevus anemicus associated with neurofibromatosis type 1 in a neonate: a case report
    Cerini, C.
    Pogliani, L.
    Mameli, C.
    Zuccotti, G. V.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2015, 150 (06): : 745 - 747
  • [37] Neurological manifestations of neurofibromatosis type 1: our experience
    Marco, S. B. Sanchez
    Pison, J. Lopez
    Escribano, C. Calvo
    Viejo, I. Gonzalez
    Gallart, M. D. Miramar
    Villagrasa, P. Samper
    NEUROLOGIA, 2022, 37 (05): : 325 - 333
  • [38] Delineating the autistic phenotype in children with neurofibromatosis type 1
    Chisholm, Anita K.
    Haebich, Kristina M.
    Pride, Natalie A.
    Walsh, Karin S.
    Lami, Francesca
    Ure, Alex
    Maloof, Tiba
    Brignell, Amanda
    Rouel, Melissa
    Granader, Yael
    Maier, Alice
    Barton, Belinda
    Darke, Hayley
    Dabscheck, Gabriel
    Anderson, Vicki A.
    Williams, Katrina
    North, Kathryn N.
    Payne, Jonathan M.
    MOLECULAR AUTISM, 2022, 13 (01)
  • [39] Rationale for haploinsufficiency correction therapy in neurofibromatosis type 1
    Frost, Michael
    Serra, Eduard
    Viskochil, David
    Korf, Bruce R.
    Mattson-Hoss, Michelle K.
    Croston, Glenn E.
    Sarnoff, Herb
    JOURNAL OF TRANSLATIONAL GENETICS AND GENOMICS, 2022, 6 (04) : 403 - 428
  • [40] Psychosocial and Socioeconomic Factors in Children with Neurofibromatosis Type 1
    Leppich, Katalin
    Schneider, Joanna
    Eismann, Caroline
    Ryczek, Monika
    Potratz, Cornelia
    Kaindl, Angela M.
    JOURNAL OF PEDIATRIC NEUROLOGY, 2022, 20 (03) : 188 - 193